Clinical trials
Completed Phase 1 Dyslipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
111 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 12 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 111 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 35 |
| AstraZeneca | 13 |
| Merck Sharp & Dohme LLC | 9 |
| Pfizer | 6 |
| Eli Lilly and Company | 4 |
| Xention Ltd | 3 |
| AJU Pharm Co., Ltd. | 2 |
| Kowa Research Institute, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Tanabe Pharma Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 111 |
| Hypertension | 22 |
| Hypercholesterolemia | 14 |
| Diabetes Mellitus, Type 2 | 7 |
| Hyperlipidemias | 7 |
| Metabolic Diseases | 5 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus | 4 |
| Hypertriglyceridemia | 4 |
| Lipid Metabolism Disorders | 4 |
Trials
Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.
11 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.